Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment.
about
Vector and reservoir control for preventing leishmaniasisPreventive measures for leishmaniasisVaccines for preventing cutaneous leishmaniasisNatural Products: Insights into Leishmaniasis Inflammatory ResponseA Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous LeishmaniasisBlack yeasts and their filamentous relatives: principles of pathogenesis and host defenseTLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasisEfficient production and purification of recombinant human interleukin-12 (IL-12) overexpressed in mammalian cells without affinity tagIn vivo efficacy of oral and intraperitoneal administration of extracts of Warburgia ugandensis (Canellaceae) in experimental treatment of Old World cutaneous leishmaniasis caused by Leishmania majorEvaluation of FcγRIIIB-NA1/NA2 Polymorphism in Visceral LeishmaniasisIdentifying vaccine targets for anti-leishmanial vaccine developmentIN VIVO AND IN VITRO ANTILEISHMANIAL EFFECTS OF METHANOLIC EXTRACT FROM BARK OF BURSERA APTERA.Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages.Literature-based discovery of IFN-gamma and vaccine-mediated gene interaction networks.Herbal extract targets in Leishmania tropica.In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.Antigen-specific T cells and cytokines detection as useful tool for understanding immunity against zoonotic infections.Prediction of T Cell Epitopes from Leishmania major Potentially Excreted/Secreted Proteins Inducing Granzyme B Production.Different Morphologies of Leishmania major Amastigotes with No Molecular Diversity in a Neglected Endemic Area of Zoonotic Cutaneous Leishmaniasis in Iran.Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).Heat shock proteins enriched-promastigotes of Leishmania major inducing Th2 immune response in BALB/c mice.Development of Leishmania vaccines: predicting the future from past and present experience.Immunopathology of leishmaniasis: an update.Detection of Leishmania siamensis DNA in saliva by polymerase chain reactionImmunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague) subsp ugandensis (Canellaceae) by BALB/c mice infected with Leishmania major.Maxadilan-simile expression in Nyssomyia neivai, a sandfly vector in an endemic region of Brazil, and its immunogenicity in patients with American tegumentary leishmaniasis.Current diagnosis and treatment of visceral leishmaniasis.A comprehensive review of patented antileishmanial agents.Current Research of Trichinellosis in ChinaRepurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.Epidemiological trend of cutaneous leishmaniasis in two endemic focus of disease, south of Iran.Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani.3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine.Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.Expression of Foxp3, TGF-β and IL-10 in American cutaneous leishmaniasis lesions.Quinolinic alkaloids from Galipea longiflora Krause suppress production of proinflammatory cytokines in vitro and control inflammation in vivo upon Leishmania infection in mice.Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.High prevalence of asymptomatic Leishmania spp. infection among liver transplant recipients and donors from an endemic area of Brazil.IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru
P2860
Q24188003-E07016AA-BDCA-457A-9913-0B6677D42048Q24234937-51469C5F-1AAC-4593-9518-8A6587F1E453Q24240664-A91C3B17-E281-4B61-8485-DC04FA59E538Q26779924-36912F36-CB01-427C-8994-274CEFD30F65Q26786195-DB6112F5-253D-465B-BFCA-845D0ECF6F4CQ27028032-F42EC7D7-CAD6-458D-8DF2-74CC5EE0EC4CQ27346402-05D4623C-1E9E-4B1E-ABAA-04359517F4FDQ28655742-BCB9D57F-0B15-40BF-9C58-4704753DC7B5Q33630552-E5E3AE89-5213-4400-BE9B-B2B7F5CEC705Q33640641-E12CFA95-F302-48D6-88AB-22010C376307Q33693899-B6BCA94F-FB31-4269-9CDA-0BEFE5EC6337Q33732878-D16B6B81-2094-4CF4-9E15-84E513BBF91FQ33869247-3250635B-DA9D-45E0-B6F7-CD66C0284325Q33960059-7B5A1C8C-785A-48BB-9F0E-19EA33850182Q34506021-A6397AE2-338E-41A0-8D4F-CA92F10B6A36Q35198753-8F842375-CAA1-4AD4-8BEF-AE8BEFB4474DQ35702943-1F82C06F-73EC-4777-98D0-041C722818ADQ35779625-56908169-20C7-4E63-B886-6A2FBC2F6FBFQ35895008-1332FFB4-FC49-4278-B048-89E8DE8A5B0EQ36062884-E42FE480-AA38-4406-AF39-3CCE07E5A005Q36680084-08EAF79D-2E4E-4923-9815-158806220CECQ36694417-01BF241A-B0C5-48C0-A0FD-23534D207656Q36700453-30491CFB-A4BE-425C-9C7E-27F665E5D2D6Q36946047-7ED76ECF-5BEA-412B-8A13-B2BEBCC68BB6Q37287681-E6D6A60A-F20D-425F-B8AA-D64296D23E35Q37624078-F8FD97C8-BC9E-4275-9707-B4703A44860DQ37626269-C4D74824-C826-4556-AE65-B9EE56CDA49CQ37778829-51216BA8-B5C6-4209-B0CD-A3D44517BEC4Q38309761-346D6EBD-4EBD-4D86-A364-6C035133C614Q38639787-C308B4FE-F916-4C91-8817-4CF9EDF9CFD0Q38939544-3F9CC5BC-1A1D-41D0-A784-739714B56082Q39161879-F9DA8C60-4865-4D2C-884D-881CF1C63EDBQ39552375-C0B0BDC8-7A6B-458D-9BE4-63BA6B288B7CQ39575305-D24DCB47-C7E9-4BCD-9AC1-FD667AF93F48Q41616344-A6173CA4-8312-46FE-8850-B32874A59526Q42252111-DE107E51-7436-465B-A6E3-00409C70CA24Q43754010-F8838AB0-E102-43BC-A93F-AE006F76F45BQ48347654-51E3A3AD-5091-4064-9484-305BD32EA1C5Q54230465-3B911E08-EBE7-4F98-9C96-32D1B188D709Q58728289-BA5E229F-E1CE-4ED6-AC1C-9990CE66BE05
P2860
Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current understandings on the ...... s in prevention and treatment.
@ast
Current understandings on the ...... s in prevention and treatment.
@en
type
label
Current understandings on the ...... s in prevention and treatment.
@ast
Current understandings on the ...... s in prevention and treatment.
@en
prefLabel
Current understandings on the ...... s in prevention and treatment.
@ast
Current understandings on the ...... s in prevention and treatment.
@en
P356
P1476
Current understandings on the ...... s in prevention and treatment.
@en
P2093
Roberts MT
P304
P356
10.1093/BMB/LDL003
P577
2005-01-01T00:00:00Z